Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets

Mutat Res. 2004 Nov 2;555(1-2):65-80. doi: 10.1016/j.mrfmmm.2004.05.019.

Abstract

Recently, chemoprevention by the use of naturally occurring substances is considered as a priority to reduce the ever-increasing incidence of cancer. The intervention of multistage carcinogenesis by modulating intracellular signaling pathways may provide molecular basis of chemoprevention with a wide variety of dietary phytochemicals. Resveratrol, a red wine polyphenol, has been studied extensively for the chemopreventive activity in the context of its ability to interfere with the multistage carcinogenesis. Numerous intracellular signaling cascades converge with the activation of nuclear factor-kappaB (NF-kappaB) and activator protein-1 (AP-1), which act independently or coordinately to regulate expression of target genes. These ubiquitous eukaryotic transcription factors mediate pleiotropic effects on cellular transformation and tumor promotion. This review aims to update the molecular mechanisms underlying chemoprevention by resveratrol with special focus on its effect on cellular signaling cascades mediated by NF-kappaB and AP-1.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Anticarcinogenic Agents / therapeutic use*
  • Chemoprevention
  • Humans
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Neoplasms / blood supply
  • Neoplasms / prevention & control*
  • Resveratrol
  • Signal Transduction / drug effects*
  • Stilbenes / therapeutic use*
  • Transcription Factor AP-1 / antagonists & inhibitors*
  • Transcription Factor AP-1 / metabolism

Substances

  • Angiogenesis Inhibitors
  • Anticarcinogenic Agents
  • NF-kappa B
  • Stilbenes
  • Transcription Factor AP-1
  • Resveratrol